跳至主要内容
临床试验/NCT06379802
NCT06379802进行中(未招募)不适用

Lifestyle Intervention With Physical Activity and Diet for Precision Health in Individuals With Overweight: a 6-month Pilot Randomized Controlled Trial (LI-PAD)

Vastra Gotaland Region1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2024年2月12日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
120
试验地点
1
主要终点
Change in body weight 1

研究概览

简要总结

The aim of this pilot randomized controlled trial LI-PAD is to identify whether a 6-month intervention approach to individually optimize lifestyle behavior, physical activity, and diet, is feasible and leads to larger improvements in body weight, cardiovascular disease risk factors, and health-related quality of life compared to simple written lifestyle advice, in individuals with overweight or obesity.

The intervention group will be offered individual support for lifestyle behavioral change (precision health) and the control group will be offered written lifestyle advice, following national recommendations. In total, 60 population-based participants and 60 controls from the Gothenburg area, aged 45-65 years, will be recruited.

详细描述

Individualized lifestyle Intervention with Physical Activity and Diet as precision health in individuals with overweight: a 6-month pilot randomized controlled trial (LI-PAD)

BACKGROUND Individuals with obesity and type 2 diabetes have an increased risk of cardiovascular disease (CVD). Lifestyle changes with physical activity (PA) and diet have been associated with temporary improvements in these risk factors. However, sustained behavior changes are difficult to achieve. In Sweden and globally, the built environment promotes overweight and obesity through high availability of cheap ultra-processed energy-dense foods and drinks and low possibility of physical activity. Although the recommendation is to apply an individualized approach, few studies have applied this in clinical practice. PA on prescription, using an individualized approach, has been partly implemented into Swedish health care, resulting in short- and long-term favorable effects of PA. However, an individualized approach to modifying diet has not yet been incorporated, despite evidence showing that interventions targeting PA and diet together have a greater effect on obesity. Another crucial limitation is that PA and diet recommendations are not developed for individual application.

Previous research has shown that it is important to consider individual adaption to medical conditions (e.g. risk profile, symptoms, comorbidities) and to psychosocial factors (e.g. preferences, barriers-facilitators, readiness-to-change). It is also know that individuals require support for behavioral change (e.g., counseling/coaching, group activities, education, nudging). Furthermore, there is a link between unhealthy food environments, unhealthy food consumptions, and food-related diseases, but results vary. Previous intervention studies have shown that an unhealthy food environment is a barrier of adherence to intended behavioral changes. However, it is unclear which components are particularly important, how much of each of them should be included, and whether freedom of choice is a more efficient option compared to offering a more standardized solution as in most randomized controlled trials (RCTs).

To prescribe optimal PA for the underlying disease, the investigators are currently developing accelerometer-based PA measures and recommendations adapted to individual fitness. The optimal diet prescription targets weight reduction, primarily as body fat, by restriction energy intake below the energy need. Although rapid early weight loss is important for sustained effects, too great energy restriction (due to unrealistic goals or applying a standard treatment) results in increased hunger and reduced metabolism, not leading to larger weight reduction when clinically applied. Research supports up to 10% weight loss at 6 months by applying a ~500 kcal/d reduction of energy intake below energy need. Energy need is most accurately determined with the doubly labeled water method but is too expensive for clinical use. An alternative method commonly used is to determine resting energy expenditure (REE), calculated from individual characteristics such as body weight, and multiplied with a factor for the PA level. However, REE determined using body weight is not accurate in obesity, and the most optimal equation considering body composition is too imprecise at an individual level. REE based on measured oxygen (O2) and carbon dioxide (CO2) exchange is preferred and can also be used to monitor the respiratory quotient (RQ=CO2/O2), which is an indicator of fat metabolism. Measured O2 and CO2 are inexpensive and can be used together with measured food intake for more individualized diet prescription and to track the effects of the intervention on metabolism and use of body fat.

The present study represents a unique progress of lifestyle intervention programs away from the more standardized randomized controlled trials to approach precision health:1) adaption to medical conditions and psychosocial factors, 2) individualized PA and diet advice based on individual and environmental measurement, 3) aids for achieving goals using education, skills training and supports (Figure 1). Although individual adaptions to medical conditions and psychosocial factors are already performed in health care, individualization of PA, diet, and support for behavioral change has rarely been implemented and evaluated. This individualization requires additional resources in health care. Therefore, it is important to determine the benefits of this approach and in future studies also follow up with cost-benefit analyses.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
45 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 45-65 years
  • A body mass index (BMI) of ≥28 and <35

排除标准

  • Known coronary artery disease (clinical symptoms/earlier event)
  • Other contraindications such as inability to understand language or unable to perform lifestyle interventions

结局指标

主要结局

Change in body weight 1

时间窗: From baseline to 6 months

Reduction in body weight (kg) in percent will be identified by using Lidén weighing scale.

Change in body weight 4

时间窗: From 3 months to 6 months (intervention group)

Reduction in body weight (kg) in percent will be identified by using Lidén weighing scale. Less weight at the 6-month follow-up than at the 3-month follow-up is a better outcome than vice versa.

Change in body weight 3

时间窗: From 1 month to 3 months (intervention group)

Reduction in body weight (kg) in percent will be identified by using Lidén weighing scale. Less weight at the 3-month follow-up than at the 1-month follow-up is a better outcome than vice versa.

Change in body weight 2

时间窗: From baseline to 1 month (intervention group)

Reduction in body weight (kg) in percent will be identified by using Lidén weighing scale. Less weight at the 1-month follow-up than at baseline is a better outcome than vice versa.

次要结局

  • Cardiovascular disease risk factor change - Waist-to-hip ratio 1(From baseline to 6 months)
  • Cardiovascular disease risk factor change - Blood pressure 3(From 1 month to 3 months (intervention group))
  • Cardiovascular disease risk factor change - Blood pressure 1(From baseline to 6 months)
  • Cardiovascular disease risk factor change - Serum (total) Cholesterol (S-Cholesterol)(From baseline to 6 months)
  • Cardiovascular disease risk factor change - Physical activity level(From baseline to 6 months)
  • Change in functional lower extremity muscle strength(From baseline to 6 months)
  • Weight in kilograms(From baseline to 6 months)
  • Cardiovascular disease risk factor change - Body Mass Index (BMI)(From baseline to 6 months)
  • Cardiovascular disease risk factor change - Waist-to-hip ratio 2(From baseline to 1 month (intervention group))
  • Cardiovascular disease risk factor change - Waist-hip-ratio 4(From 3 months to 6 months (intervention group))
  • Cardiovascular disease risk factor change - Blood pressure 4(From 3 month to 6 months (intervention group))
  • Cardiovascular disease risk factor change - Blood pressure 2(From baseline to 1 month (intervention group))
  • Cardiovascular disease risk factor change - Long-term blood glucose control using glycated haemoglobin (HbA1c)(From baseline to 6 months)
  • Cardiovascular disease risk factor change - High density lipoprotein (HDL)(From baseline to 6 months.)
  • Cardiovascular disease risk factor change - Low densitiy lipoprotein (LDL)(From baseline to 6 months.)
  • Cardiovascular disease risk factor change - Triglycerides(From baseline to 6 months.)
  • Length in cm(From baseline to 6 months)
  • Cardiovascular disease risk factor change - Waist-to-hip-ratio 3(From 1 month to 3 months (intervention group))
  • Change in upper extremity muscle strength - Hand grip strength(From baseline to 6 months)
  • Change in resting energy expenditure 4(From 3 months to 6 months (intervention group))
  • Change in respiratory quotient 1(From baseline to 6 months)
  • Cardiovascular disease risk factor change - Aerobic fitness (predicted V02 max)(From baseline to 6 months.)
  • Change in respiratory quotient 3(From 1 month to 3 months (intervention group))
  • Change in respiratory quotient 4(From 3 months to 6 months (intervention group))
  • Change in health-related quality of life - Index score(From baseline to 6 months)
  • Change in self-reported physical activity level(From baseline to 6 months)
  • Change in muscle strength - Shoulder flexion(From baseline to 6 months)
  • Cardiovascular disease risk factor change - Healthy food intake(From baseline to 6 months)
  • Change in resting energy expenditure 2(From baseline to 1 month (intervention group))
  • Change in resting energy expenditure 3(From 1 month to 3 months (intervention group))
  • Change in health-related quality of life - Proportions of problems in five dimensions(From baseline to 6 months)
  • Change in exposure pattern to the food environment(From baseline to 6 months)
  • Change in muscle strength - Ankle Plantar(From baseline to 6 months)
  • Change in resting energy expenditure 1(From baseline to 6 months)
  • Change in respiratory quotient 2(From baseline to 1 month (intervention group))
  • Change in exposure pattern to the built environment(From baseline to 6 months)
  • Process evaluation measure 1 - Extent to which intervention was implemented as planned(During the 6 months intervention (intervention group))
  • Process evaluation measure 6A - Perceived facilitators(After 6 months intervention (intervention group))
  • Change in health-related quality of life - Visual analog score of present health status(From baseline to 6 months)
  • Change in health-related quality of life - Health status categories(From baseline to 6 months)
  • Process evaluation measure 2 - Number of sessions of each intervention component delivered(During the 6 months intervention (intervention group))
  • Process evaluation measure 3 - Number of sessions of each intervention component received(During the 6 months intervention (intervention group))
  • Process evaluation measure 7 - Reach(From start of recruitment to end of 6 months followup measurements)
  • Process evaluation measure 4 - Satisfaction with individual lifestyle counselling(After 6 months intervention (intervention group))
  • Process evaluation measure 6B - Perceived barriers(After 6 months intervention (intervention group))
  • Process evaluation measure 5 - Satisfaction with the lifestyle school(After 6 months intervention (intervention group))

研究者

发起方
Vastra Gotaland Region
申办方类型
Other Gov
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验